Ligand Pharmaceuticals has patents filed for the manufacture and therapeutic use of certain compounds occupying several stated chemical structures, which are intended for use as selective androgen receptor modulators. The patent is filed under the following designations: US8519158 B2, US8865918, US9359285, US20070254875, US20140005186, US20150099720, and WO2005090282A1. The patents will expire on March 12, 2025. These patents effectively protect any future capitalization upon VK5211 in the market by Viking and Ligand through their licensing agreement. 
While everyone claims to know someone who remembered they had 500 Bitcoin stuffed in an old hard drive somewhere, remaining heavily invested in the cryptocurrency market at this point would require ignoring or rationalizing away just a few tiny flags. Those might include the time thieves ran off with millions in Bitcoin from underground site Sheep Marketplace, or that time a former federal investigator stole $820,000 in Bitcoin from Silk Road, or that time an estimated $450 million in Bitcoin disappeared from trading hub Mt. Gox.